MVC-COV1901: Clinical Trials

6 trials of MVC-COV1901, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 3 Phase 1, 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Unknown 1
Phase 33Completed 3
Phase 21Unknown 1

Follow MVC-COV1901: new trials by email Literature Review of MVC-COV1901 trials Research Report on MVC-COV1901

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above
MVC-COV1901, AZD1222 - COVID-19 Vaccine
Phase 3CompletedMedigen Vaccine Biologics Corp.2502022-07-302023-10-23
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222
MVC-COV1901, AZD1222 - COVID-19 Vaccine
Phase 3CompletedMedigen Vaccine Biologics Corp.2002022-07-092023-10-23
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19
MVC-COV1901, MVC-COV1901(Beta)-15, MVC-COV1901(Beta)-25 - COVID-19 Vaccine
Phase 1CompletedMedigen Vaccine Biologics Corp.1072022-05-062023-03-15
The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine
BNT162b2, mRNA-1273, MVC-COV1901 - COVID-19, Breakthrough Infection
Phase 1 / Phase 2UnknownChang Gung Memorial Hospital3402021-11-302022-07-25
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults
MVC-COV1901, AZD1222 - Covid19 Vaccine
Phase 3CompletedMedigen Vaccine Biologics Corp.10302021-10-082022-09-30
A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19
MVC-COV1901 - COVID-19
Phase 1CompletedMedigen Vaccine Biologics Corp.452020-10-072022-01-31

Conditions studied

COVID-19 (2)  ·  Breakthrough Infections (1)

Sponsors

Medigen Vaccine Biologics Corp. (5)  ·  Chang Gung Memorial Hospital (1)

Countries

Taiwan (3)  ·  Paraguay (2)  ·  Thailand (1)

Top investigators

Allen Lien, MD. Dr.PH (2)  ·  Allen Lien, MD Dr.Ph (1)  ·  Cheng-Hsun Chiu, MD, PhD (1)  ·  Luis Francisco Armoa Garcia, MD.Ph.D. (1)

Results publications

PMID 34222848, PMID 35579840, PMID 36399969